Renal Replacement Therapy (Sep 2018)
The Japanese Clinical Practice Guideline for acute kidney injury 2016
- Kent Doi,
- Osamu Nishida,
- Takashi Shigematsu,
- Tomohito Sadahiro,
- Noritomo Itami,
- Kunitoshi Iseki,
- Yukio Yuzawa,
- Hirokazu Okada,
- Daisuke Koya,
- Hideyasu Kiyomoto,
- Yugo Shibagaki,
- Kenichi Matsuda,
- Akihiko Kato,
- Terumasa Hayashi,
- Tomonari Ogawa,
- Tatsuo Tsukamoto,
- Eisei Noiri,
- Shigeo Negi,
- Koichi Kamei,
- Hirotsugu Kitayama,
- Naoki Kashihara,
- Toshiki Moriyama,
- Yoshio Terada,
- The Japanese Clinical Practice Guideline for Acute Kidney Injury 2016 Committee
Affiliations
- Kent Doi
- Department of Acute Medicine, The University of Tokyo
- Osamu Nishida
- Department of Anesthesiology and Critical Care Medicine, Fujita Health University School of Medicine
- Takashi Shigematsu
- Department of Nephrology, Wakayama Medical University
- Tomohito Sadahiro
- Department of Emergency and Critical Care Medicine, Tokyo Women’s Medical University Yachiyo Medical Center
- Noritomo Itami
- Kidney Center, Department of Surgery, Nikko Memorial Hospital
- Kunitoshi Iseki
- Clinical Research Support Center, Tomishiro Central Hospital
- Yukio Yuzawa
- Department of Nephrology, Fujita Health University School of Medicine
- Hirokazu Okada
- Department of Nephrology and General Internal Medicine, Saitama Medical University
- Daisuke Koya
- Division of Anticipatory Molecular Food Science and Technology, Department of Diabetology and Endocrinology, Kanazawa Medical University
- Hideyasu Kiyomoto
- Department of Community Medical Supports, Tohoku Medical Megabank Organization, Tohoku University
- Yugo Shibagaki
- Division of Nephrology and Hypertension, St. Marianna University School of Medicine
- Kenichi Matsuda
- Department of Emergency and Critical Care Medicine, University of Yamanashi School of Medicine
- Akihiko Kato
- Blood Purification Unit, Hamamatsu University Hospital
- Terumasa Hayashi
- Department of Kidney Disease and Hypertension, Osaka General Medical Center
- Tomonari Ogawa
- Nephrology and Blood Purification, Saitama Medical Center, Saitama Medical University
- Tatsuo Tsukamoto
- Department of Nephrology, Graduate School of Medicine, Kyoto University
- Eisei Noiri
- Department of Nephrology and Endocrinology, The University of Tokyo
- Shigeo Negi
- Department of Nephrology, Wakayama Medical University
- Koichi Kamei
- Division of Nephrology and Rheumatology, National Center for Child Health and Development
- Hirotsugu Kitayama
- Department of Nephrology, Shizuoka Children’s Hospital
- Naoki Kashihara
- Department of Nephrology and Hypertension, Kawasaki Medical School
- Toshiki Moriyama
- Health Care Division, Health and Counseling Center, Osaka University
- Yoshio Terada
- Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Kochi University
- The Japanese Clinical Practice Guideline for Acute Kidney Injury 2016 Committee
- DOI
- https://doi.org/10.1186/s41100-018-0177-4
- Journal volume & issue
-
Vol. 4,
no. 1
pp. 1 – 55
Abstract
Abstract Acute kidney injury (AKI) is a syndrome which has a broad range of etiologic factors depending on different clinical settings. Because AKI has significant impacts on prognosis in any clinical settings, early detection and intervention are necessary to improve the outcomes of AKI patients. This clinical guideline for AKI was developed by a multidisciplinary approach with nephrology, intensive care medicine, blood purification, and pediatrics. Of note, clinical practice for AKI management which was widely performed in Japan was also evaluated with comprehensive literature search.
Keywords
- Acute kidney injury
- Atrial natriuretic peptide
- Biomarker
- Blood purification
- Long-term follow-up
- Nafamostat mesilate
